CCDN1 rs603965 polymorphism may serve as a genetic biomarker of brain tumor: A meta‐analysis of 5,769 subjects

Molecular Genetics & Genomic Medicine

  ^{1    2    3} 

[1] Department of Endocrinology, Huzhou Hospital of Traditional Chinese Medicine Affiliated Zhejiang University of Traditional Chinese Medicine, Huzhou, Zhejiang, China;Department of Nephrology, Huzhou Hospital of Traditional Chinese Medicine Affiliated Zhejiang University of Traditional Chinese Medicine, Huzhou, Zhejiang, China;Department of Neurosurgery, Ningbo No. 1 Hospital, Ningbo, Zhejiang, China;

关键词: brain tumor;    cyclin D1 (CCND1);    glioma;    meta‐analysis;    rs603965 polymorphism;   

DOI  :  10.1002/mgg3.655

来源: publisher

【 授权许可】

Unknown